BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 8157362)

  • 1. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG
    Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line.
    Cuomo L; Ramquist T; Trivedi P; Wang F; Klein G; Masucci MG
    Int J Cancer; 1992 Jul; 51(6):949-55. PubMed ID: 1322379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
    Brooks L; Yao QY; Rickinson AB; Young LS
    J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
    J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
    Vockerodt M; Haier B; Buttgereit P; Tesch H; Kube D
    Virology; 2001 Feb; 280(2):183-98. PubMed ID: 11162833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
    Contreras-Salazar B; Klein G; Masucci MG
    J Virol; 1989 Jun; 63(6):2768-72. PubMed ID: 2542588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
    Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
    Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
    J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
    Klein SC; Jücker M; Abts H; Tesch H
    Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.